Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas
The Lancet Gastroenterology & Hepatology in conversation with
English - June 14, 2022 15:00 - 9 minutes - 6.79 MBLife Sciences Science Education gut intestines ibs ibd bowel medicine research Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Juan Pablo Arab on NAFLD public health policies in the Americas
Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease.
Read the full article:
Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II)
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv